Top Headlines and Trials from 2016: Time for Change?

Dr. Katelyn Halpape, BSP, PharmD, ACPR
Clinical Pharmacy Specialist – Neurosciences, Vancouver General Hospital
This presentation will review the key studies and headlines from 2016 and how we can apply this information to practice.

Trials Reviewed:
HOPE-3 (Cholesterol & BP Lowering)
EMPA-REG (Type 2 Diabetes)
LEADER (Type 2 Diabetes)
ATTACH-II (Intracranial Hemorrhage)

Handout

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s